Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 29,835 | 26,465 | 15,404 | 13,187 | 11,312 |
| Cost of Goods | 11,144 | 9,949 | 8,005 | 8,109 | 8,229 |
| Gross Profit | 18,691 | 16,517 | 7,399 | 5,078 | 3,083 |
| Operating Expenses | 10,284 | 11,077 | 6,809 | 8,462 | 10,723 |
| Operating Income | 8,551 | 6,388 | 595 | -3,275 | -7,411 |
| Other Income | 1,241 | 389 | 144 | 240 | 662 |
| Pre-tax Income | 9,792 | 6,777 | 739 | -3,035 | -6,749 |
| Income Tax | 3,899 | -4,413 | -88 | 5 | 9 |
| Net Income Continuous | 5,893 | 11,190 | 827 | -3,040 | -6,758 |
| Net Income | $5,893 | $11,190 | $827 | $-3,040 | $-6,758 |
| EPS Basic Total Ops | 0.57 | 1.11 | 0.08 | -0.31 | -0.68 |
| EPS Basic Continuous Ops | 0.57 | 1.11 | 0.08 | -0.31 | -0.68 |
| EPS Diluted Total Ops | 0.52 | 0.98 | 0.08 | -0.31 | -0.68 |
| EPS Diluted Continuous Ops | 0.52 | 0.98 | 0.08 | -0.31 | -0.68 |
| EBITDA(a) | $9,010 | $7,097 | $1,601 | $-2,180 | $-6,326 |